Complex EGFR mutations in lung cancer are generally noted through NGS‐based molecular tests and Kohsaka et al. recently reported that almost one‐fifth of NSCLC cases with the EGFR L858R mutation (38/195 cases) actually harbor comutations with other parts of the EGFR gene.10 This evidence concerns the gene EGFR and non-small cell lung carcinoma.